Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials-Reference-Cited by-同舟云学术

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

Published:2022-06 Issue:4 Volume:40 Page:704-715
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Bruzzese Antonella¹,Derudas Daniele²,Galli Monica³,Martino Enrica Antonia¹,Rocco Stefano⁴,Conticello Concetta⁵,Califano Catello⁶,Giuliani Nicola⁷,Mangiacavalli Silvia⁸,Farina Giuliana⁹,Lombardo Alessandra¹⁰,Brunori Marino¹¹,Rossi Elena¹²,Antonioli Elisabetta¹³,Ria Roberto¹⁴^ORCID,Zambello Renato¹⁵,Di Renzo Nicola¹⁶,Mele Giuseppe¹⁷^ORCID,Marcacci Gianpaolo¹⁸,Pietrantuono Giuseppe¹⁹,Palumbo Gaetano²⁰,Cascavilla Nicola²¹,Cerchione Claudio²²,Belotti Angelo²³,Criscuolo Clelia²⁴,Uccello Giuseppina²⁵,Curci Paola²⁶,Vigna Ernesto¹,Mendicino Francesco¹^ORCID,Iaccino Enrico²⁷,Mimmi Selena²⁷,Botta Cirino¹²⁸^ORCID,Vincelli Donatella²⁹^ORCID,Sgherza Nicola²⁶,Bonalumi Angela³⁰,Cupelli Luca³¹,Stocchi Raffaella³²,Martino Massimo³³^ORCID,Ballanti Stelvio³⁴,Gangemi Dominella³⁵,Gagliardi Alfredo³⁶,Gamberi Barbara³⁷,Pompa Alessandra³⁸,Tripepi Giovanni³⁹,Frigeri Ferdinando⁹,Consoli Ugo²⁷,Bringhen Sara⁴⁰,Zamagni Elena⁴¹,Patriarca Francesca³²,De Stefano Valerio¹²,Di Raimondo Francesco⁵,Palmieri Salvatore⁴^ORCID,Petrucci Maria Teresa⁴²,Offidani Massimo⁴³,Musto Pellegrino²⁶⁴⁴,Boccadoro Mario⁴⁰,Cavo Michele⁴¹,Neri Antonino⁴⁵,Morabito Fortunato⁴⁶⁴⁷,Gentile Massimo¹

Affiliation:

1. Hematology Unit Azienda Ospedaliera of Cosenza Cosenza Italy

2. Department of Hematology Businco Hospital Cagliari Italy

3. Hematology and Bone Marrow Transplant Unit Azienda Socio‐Sanitaria Territoriale‐Papa Giovanni XXIII Bergamo Italy

4. Hematology Unit Napoli Italy

5. Department of Medical and Surgical Specialties Hematology Section University of Catania Catania Italy

6. Onco‐hematology Unit Ospedale Umberto I Nocera Inferiore Italy

7. Hematology Unit Parma University Hospital Parma Italy

8. Department of Hematology‐Oncology Hematology Division IRCCS Fondazione Policlinico San Matteo Pavia Italy

9. UOC Ematologia a Indirizzo Oncologico AORN “Sant’Anna e San Sebastiano” Caserta Italy

10. Onco‐hematology Unit Azienda Ospedaliera Santa Maria of Terni Terni Italy

11. Internal Medicine, Ospedale S. Croce Azienda Ospedaliera Ospedali Riuniti Marche Nord Fano Italy

12. Istituto di Ematologia Università Cattolica Fondazione Policlinico Gemelli IRCCS Roma Italy

13. Hematology Unit Careggi Hospital Florence Italy

14. Department of Biomedical Science University of Bari “Aldo Moro” Medical School Internal Medicine “G. Baccelli” Bari Italy

15. Department of Medicine Hematology and Clinical Immunology Section Padua University School of Medicine Padua Italy

16. Hematology Unit Lecce Italy

17. Hematology Unit Brindisi Italy

18. Hematology and Bone Marrow Transplant Unit Istituto Nazionale Tumori Fondazione ‘G. Pascale’, IRCCS Napoli Italy

19. Unit of Hematology and Stem Cell Transplantation IRCCS‐CROB Referral Cancer Center of Basilicata Rionero in Vulture (Pz) Italy

20. Department of Hematology Hospital University Riuniti Foggia Italy

21. Department of Hematology and Bone Marrow Transplant IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo Italy

22. Hematology Unit IRCCS ‐ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola Italy

23. Hematology Unit A.O. Spedali Civili Brescia Italy

24. Hematology Unit AO S.G. Moscati Aversa (CE) Italy

25. Hematology Department G. Garibaldi Hospital Catania Italy

26. Unit of Hematology and Stem Cell Transplantation AOUC Policlinico Bari Italy

27. Department of Experimental and Clinical Medicine University “Magna Graecia” of Catanzaro Catanzaro Italy

28. Department of Health Promotion Mother and Child Care Internal Medicine and Medical Specialties University of Palermo Palermo Italy

29. Department of Hemato‐Oncology and Radiotherapy Hematology Unit Great Metropolitan Hospital “Bianchi‐Melacrino‐Morelli” Reggio Calabria Italy

30. Department of Medicine Section of Hematology University of Verona Verona Italy

31. Hematology Unit and Pathology Department S. Eugenio Hospital Rome Rome Italy

32. Hematology DISM University of Udine Udine Italy

33. Department of Hemato‐Oncology and Radiotherapy Stem Cell Transplantation Unit Great Metropolitan Hospital “Bianchi‐Melacrino‐Morelli” Reggio Calabria Italy

34. Institute of Haematology and Stem Cell Transplantation Ospedale Santa Maria della Misericordia University of Perugia Perugia Italy

35. Hematology Unit Fabrizio Spaziani Hospital Frosinone Italy

36. Complex Operative Unit of Hematology S. Maria di Loreto Nuovo Hospital Napoli Italy

37. Hematology Unit Azienda USL‐IRCCS of Reggio Emilia Reggio Emilia Italy

38. Hematology Unit Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano Italy

39. Nephrology Center of National Research Institute of Biomedicine and Molecular Immunology Reggio Calabria Italy

40. Division of Hematology University of Torino AOU Città della Salute e della Scienza di Torino Torino Italy

41. Seràgnoli Institute of Hematology and Medical Oncology University of Bologna Bologna Italy

42. Department of Cellular Biotechnologies and Hematology Sapienza University of Rome Rome Italy

43. Hematology Unit AOU Ospedali Riuniti di Ancona Foggia Italy

44. Department of Emergency and Organ Transplantation “Aldo Moro” University School of Medicine Bari Italy

45. Scientific Directorate Azienda USL‐IRCCS of Reggio Emilia Reggio Emilia Italy

46. Hemato‐Oncology Department Augusta Victoria Hospital of Jerusalem Jerusalem Israel

47. Biotechnology Research Unit AO di Cosenza Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3031

Reference23 articles.

1. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

2. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

3. Treatment of relapsed multiple myeloma: Evidence-based recommendations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future;International Journal of Molecular Sciences;2023-10-27

2. Teclistamab‐cqyv in multiple myeloma;European Journal of Haematology;2023-10-17

3. Elotuzumab in multiple myeloma;Expert Opinion on Biological Therapy;2022-11-14

4. Urolithin A induces protective autophagy to alleviate inflammation, oxidative stress, and endoplasmic reticulum stress in pediatric pneumonia;Allergologia et Immunopathologia;2022-11-01

5. Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials;Frontiers in Oncology;2022-07-18